Company Profile

UbiquiTx focuses on leveraging machine learning and protein engineering to develop programmable protein-modulating therapies. Firm's AI/ML peptide guide design platform allows us to modulate almost any target protein, allowing for CRISPR-like programmability of protein modulation. The UbiquiTx platform enables fast access to intractable protein targets that have long evaded the industry and is generalizable and applicable to any of nature’s PTMs for programmable protein modulation.